Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 698 (LINC00698) is a long non-coding RNA gene located on chromosome 3. It does not encode a protein and instead functions as a regulatory RNA molecule. LINC00698 is upregulated in melanoma stem cells, where it promotes tumorigenicity by supporting cell proliferation, inhibiting apoptosis, and maintaining stemness. Mechanistically, LINC00698 exerts its effects through two main actions: (1) acting as a molecular "sponge" for miR-3132, thereby upregulating the pro-tumorigenic transcription factor TCF7, and (2) binding directly to the protein hnRNPM, stabilizing it and promoting cancer cell survival and stem cell-like properties. While LINC00698 is not a classical therapeutic receptor or drug target, it is emerging as a potential biomarker and regulatory node in tumor biology, particularly in melanoma[2][3][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 698 (LINC00698).